Skip to content
10-K

Annual Report

BIOGEN INC. BIIB

0000875045-26-000013

← back to feed
Filed
Feb 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 4, 2026 146.76M sh
Shares Diluted FY 2025 · Dec 31, 2025 147.1M sh
Shares Diluted FY 2025 · Dec 31, 2024 145.9M sh
Shares Diluted FY 2025 · Dec 31, 2023 145.6M sh
Capex FY 2025 · Dec 31, 2025 $153.8M
Capex FY 2025 · Dec 31, 2024 $153.7M
Capex FY 2025 · Dec 31, 2023 $277M
Operating Cash Flow FY 2025 · Dec 31, 2025 $2.2B
Operating Cash Flow FY 2025 · Dec 31, 2024 $2.88B
Operating Cash Flow FY 2025 · Dec 31, 2023 $1.55B
Long Term Debt FY 2025 · Dec 31, 2025 $6.29B
Short Term Debt FY 2025 · Dec 31, 2025 $0
Short Term Debt FY 2025 · Dec 31, 2024 $1.75B
Current Liabilities FY 2025 · Dec 31, 2025 $3.35B
Current Liabilities FY 2025 · Dec 31, 2024 $5.53B
Total Liabilities FY 2025 · Dec 31, 2025 $11.18B
Total Liabilities FY 2025 · Dec 31, 2024 $11.33B
Current Assets FY 2025 · Dec 31, 2025 $8.97B
Current Assets FY 2025 · Dec 31, 2024 $7.46B
Total Assets FY 2025 · Dec 31, 2025 $29.44B
Total Assets FY 2025 · Dec 31, 2024 $28.05B
Eps Diluted FY 2025 · Dec 31, 2025 $8.79
Eps Diluted FY 2025 · Dec 31, 2024 $11.18
Eps Diluted FY 2025 · Dec 31, 2023 $7.97
Eps Basic FY 2025 · Dec 31, 2025 $8.83
Eps Basic FY 2025 · Dec 31, 2024 $11.21
Eps Basic FY 2025 · Dec 31, 2023 $8.02
Sga Expense FY 2025 · Dec 31, 2025 $2.43B
Sga Expense FY 2025 · Dec 31, 2024 $2.4B
Sga Expense FY 2025 · Dec 31, 2023 $2.55B
Net Income FY 2025 · Dec 31, 2025 $1.29B
Net Income FY 2025 · Dec 31, 2024 $1.63B
Net Income FY 2025 · Dec 31, 2023 $1.16B
Revenue FY 2025 · Dec 31, 2025 $9.89B
Revenue FY 2025 · Dec 31, 2024 $9.68B
Revenue FY 2025 · Dec 31, 2023 $9.84B